Updated Jul 16, 2026 · Last SEC filing 2026-07-16
Mineralys Therapeutics, Inc. (MLYS) has filed 11 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-07-16. 4 Form 8-K material event filings were reported by MLYS in the last 90 days. 16 Form 144 notices of proposed sale were filed for MLYS stock. InsiderAlpha tracks every MLYS SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.
| SIC classification | Pharmaceutical Preparations (SIC 2834) |
|---|---|
| SEC CIK | 0001933414 |
| Form 4 filings (90d) | 11 |
|---|---|
| Form 8-K filings (90d) | 4 |
| Form 144 notices (90d) | 16 |
| Latest Form 4 filing | 2026-07-16 |
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Rodman David Malcom | Chief Medical Officer | S — Open-market sale [10b5-1] | 6.3K | $26.61 | $169K | SEC | |
| Rodman David Malcom | Chief Medical Officer | S — Open-market sale [10b5-1] | 14.1K | $27.58 | $388K | SEC | |
| Rodman David Malcom | Chief Medical Officer | M — Option exercise [10b5-1] | 4.2K | $14.25 | $59K | SEC | |
| Rodman David Malcom | Chief Medical Officer | M — Option exercise [10b5-1] | 6.3K | $1.08 | $7K | SEC | |
| Rodman David Malcom | Chief Medical Officer | M — Option exercise [10b5-1] | 3.5K | $10.20 | $36K | SEC | |
| Congleton Jon | Chief Executive Officer | S — Open-market sale [10b5-1] | 10.7K | $27.24 | $291K | SEC | |
| Rodman David Malcom | Chief Medical Officer | M — Option exercise | 2.2K | $16.00 | $35K | SEC | |
| Rodman David Malcom | Chief Medical Officer | S — Open-market sale | 2.2K | $30.30 | $66K | SEC | |
| Congleton Jon | Chief Executive Officer | S — Open-market sale | 17.0K | $26.82 | $456K | SEC | |
| Congleton Jon | Chief Executive Officer | S — Open-market sale | 58.0K | $25.94 | $1.50M | SEC | |
| Warren Eric | Chief Commercial Officer | S — Open-market sale | 104.1K | $25.90 | $2.70M | SEC | |
| Warren Eric | Chief Commercial Officer | M — Option exercise | 104.1K | $13.24 | $1.38M | SEC | |
| Rodman David Malcom | Chief Medical Officer | S — Open-market sale | 4.6K | $25.00 | $115K | SEC | |
| Rodman David Malcom | Chief Medical Officer | M — Option exercise | 417 | $15.44 | $6K | SEC | |
| Rodman David Malcom | Chief Medical Officer | M — Option exercise | 4.2K | $14.25 | $59K | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for Mineralys Therapeutics, Inc. (MLYS). Updated in real time as new filings are submitted to the SEC.
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| Rodman David Malcom | 42 | $2.29M |
| Congleton Jon | 3 | $2.25M |
| Warren Eric | 3 | $4.07M |
| Karydas Daphne | 3 | $111K |
Form 144 must be filed before insiders sell restricted or control stock above SEC thresholds. A cluster of Form 144 notices often precedes a wave of insider distribution.
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in MLYS insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
Open the live MLYS dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.